By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
Achillion (ACHN) Announces Appointments Of Martha Manning As General Counsel And Amy Jennings As Head Of Regulatory Affairs 2/3/2016 8:02:41 AM
Achillion (ACHN) Appoints Dr. Joel Barrish As Chief Scientific Officer 1/4/2016 7:12:25 AM
Achillion (ACHN) Appoints Dr. Frank Verwiel To Board Of Directors 12/17/2015 8:15:30 AM
Achillion (ACHN) Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society of Hematology And Nomination Of ACH-4471, A Novel Small Molecule Factor D Inhibitor, For Clinical Development 12/7/2015 8:27:46 AM
Achillion (ACHN) Reports Third Quarter And Nine Month 2015 Financial Results 11/6/2015 7:13:33 AM
Achillion (ACHN) Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society of Hematology Detailing Novel Results With Factor D Inhibitors 11/5/2015 8:43:03 AM
Achillion (ACHN) To Present At The Credit Suisse 24th Annual Healthcare Conference 11/2/2015 7:57:32 AM
Achillion (ACHN) Announces That Janssen Pharmaceutical Has Initiated A Phase IIa Study To Evaluate The Combination Of AL-335, Odalasvir (ACH-3102), And Simeprevir For The Treatment Of Genotype 1 Chronic HCV 10/16/2015 7:43:41 AM
Gilead (GILD) Rumored to be Eying Achillion (ACHN)...Again 8/17/2015 5:50:01 AM
Achillion (ACHN) Reports Second Quarter And Six Month 2015 Financial Results 8/10/2015 10:14:28 AM
12345678910...
//-->